Roche Launches Cobas Pulse System In Select Countries - Quick Facts

Roche (RHHBY) announced the launch of the cobas pulse system in select countries accepting the CE Mark. The device marks Roche Diagnostics' newest generation of connected point of care solutions for professional blood glucose management. The cobas pulse system's portability and Android-based interface make using it as simple as a smartphone, the company noted.

Following first commercial availability under CE Mark in select markets, the company plans to seek CE IVDR and FDA clearance for the cobas pulse system in other global markets throughout 2022.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The Federal Communications Commission or FCC has granted SpaceX Services, Inc. authorization to use its Starlink satellite internet system on vehicles in motion. SpaceX, owned by Elon Musk, is allowed to operate consumer and enterprise Ku-band Earth Stations in Motion or ESIM using frequencies allocated to the fixed satellite service. The approval would help the company to expand its services to Loud Muscle Science, LLC is recalling certain Launch Sequence products in the United States and Canada citing the presence of undeclared Tadalafil, the U.S. Food and Drug Administration said. These tainted Launch Sequence Capsule products are marketed as dietary supplements for male sexual enhancement. The U.S. Food and Drug Administration announced the intended availability of around 17 million bottles equivalent of general infant formula to be imported from New Zealand and Ireland. Under the FDA's enforcement discretion to source more infant formula to the U.S., French food company Danone SA will send 555,000 cans Aptamil Gold Plus from New Zealand.
Follow RTT